Literature DB >> 869924

The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

R B Sim, R R Porter, K B Reid, I Gigli.   

Abstract

The subcomponents C1r and C1s and their activated forms C-1r and C-1s were each found to have mol.wts. in dissociating solvents of about 83000. The amino acid compositions of each were similar, but there were significant differences in the monosaccharide analyses of subcomponents C1r and C1s, whether activated or not. Subcomponents C1r and C1s have only one polypeptide chain, but subcomponents C-1r and C-1s each contain two peptide chains of approx. mol.wts. 56000 ("a" chain) and 27000 ("b" chain). The amino acid analyses of the "a" chains from each activated subcomponent are similar, as are those of the "b" chains. The N-terminal amino acid sequence of 29 residues of the C-1s "a" chain was determined, but the C-1r "a" chain has blocked N-terminal amino acid. The 20 N-terminal residues of both "b" chains are similar, but not identical, and both show obvious homology with other serine proteinases. The difference in polysaccharide content of the subcomponents C-1r and C-1s is most marked in the 'b' chains. When tested on synthetic amino acid esters, subcomponent C-1r hydrolysed both lysine and tyrosine ester bonds, but subcomponent C-1r did not hydrolyse any amino acid esters tested nor any protein substrate except subcomponent C1s. The lysine esterase activity of subcomponent C1s provides a rapid and sensitive assay of the subcomponent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 869924      PMCID: PMC1164687          DOI: 10.1042/bj1630219

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  MOLECULAR EXCLUSION AND RESTRICTED DIFFUSION PROCESSES IN MOLECULAR-SIEVE CHROMATOGRAPHY.

Authors:  G K ACKERS
Journal:  Biochemistry       Date:  1964-05       Impact factor: 3.162

2.  STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES.

Authors:  A L HAINES; I H LEPOW
Journal:  J Immunol       Date:  1964-03       Impact factor: 5.422

3.  Estimation of the size of antigens by gel diffusion methods.

Authors:  A C ALLISON; J H HUMPHREY
Journal:  Nature       Date:  1959-06-06       Impact factor: 49.962

4.  A method for determining the sedimentation behavior of enzymes: application to protein mixtures.

Authors:  R G MARTIN; B N AMES
Journal:  J Biol Chem       Date:  1961-05       Impact factor: 5.157

5.  Isolation and comparison of the proenzyme and activated forms of the human serum complement subcomponents C1r and C1s.

Authors:  R B Sim; R R Porter
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

6.  The unactivated form of the first component of human complement, C1.

Authors:  I Gigli; R R Porter; R B Sim
Journal:  Biochem J       Date:  1976-09-01       Impact factor: 3.857

7.  Primary structure of peptides released during activation of human plasminogen by urokinase.

Authors:  B Wiman
Journal:  Eur J Biochem       Date:  1973-11-01

8.  The activation of Cls with purified Clr.

Authors:  K Sakai; R M Stroud
Journal:  Immunochemistry       Date:  1974-04

9.  Studies on the activation of a proesterase associated with partially purified first component of human complement.

Authors:  I H LEPOW; O D RATNOFF; L R LEVY
Journal:  J Exp Med       Date:  1958-03-01       Impact factor: 14.307

10.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

View more
  33 in total

1.  The isolation and structure of C4, the fourth component of human complement.

Authors:  I Gigli; I von Zabern; R R Porter
Journal:  Biochem J       Date:  1977-09-01       Impact factor: 3.857

2.  The quaternary structure in solution of human complement subcomponent C1r2C1s2.

Authors:  S J Perkins; A S Nealis
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

3.  Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.

Authors:  M B Lacroix; C A Aude; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

4.  Genetic studies of low-abundance human plasma proteins. XIII. Population genetics of C1R complement subcomponent and description of new variants.

Authors:  M I Kamboh; L A Lyons; R E Ferrell
Journal:  Am J Hum Genet       Date:  1989-01       Impact factor: 11.025

5.  Domain structure and associated functions of subcomponents C1r and C1s of the first component of human complement.

Authors:  C L Villiers; G J Arlaud; M G Colomb
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

6.  Molecular modelling of human complement subcomponent C1q and its complex with C1r2C1s2 derived from neutron-scattering curves and hydrodynamic properties.

Authors:  S J Perkins
Journal:  Biochem J       Date:  1985-05-15       Impact factor: 3.857

7.  Genetic studies of low abundance human plasma proteins. III. Polymorphism of the C1R subcomponent of the first complement component.

Authors:  M I Kamboh; R E Ferrell
Journal:  Am J Hum Genet       Date:  1986-12       Impact factor: 11.025

8.  Purification and characterization of subcomponent C1q of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

9.  Assignment of the complement serine protease genes C1r and C1s to chromosome 12 region 12p13.

Authors:  V C Nguyen; M Tosi; M S Gross; O Cohen-Haguenauer; C Jegou-Foubert; M F de Tand; T Meo; J Frézal
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

10.  The purification and characterization of subcomponent C1s of the first component of bovine complement.

Authors:  R D Campbell; N A Booth; J E Fothergill
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.